Biotech Investors & VC Firms in Netherlands

42 firms in this list, with a median first check of $810K. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
M Ventures 11 people	Los Angeles	US	Seed–Series A	$10.8M	+ Add to CRM
b2venture 11 people	Berlin	DE	Pre-Seed–Late Stage	$270K – $5.4M	+ Add to CRM
EQT Life Sciences 11 people	Amsterdam	NL	Series A–Late Stage	$10.8M – $64.8M	+ Add to CRM
European Circular Bioeconomy Fund 11 people	Bonn	DE	Growth–Late Stage	$2.7M – $10.8M	+ Add to CRM
Gilde Healthcare 11 people	Utrecht	NL	Seed–Late Stage	$1.1M – $32.4M	+ Add to CRM
Korys 11 people	Halle	BE	Growth	$5.4M	+ Add to CRM
Oost NL 11 people	Apeldoorn	NL	Seed–Late Stage	$108K – $2.7M	+ Add to CRM
PAI Partners 11 people	Paris	FR	—	$108M – $324M	+ Add to CRM
Brightlands Venture Partners 9 people	Geleen	NL	Seed–Series B	$540K – $2.2M	+ Add to CRM
dsm-firmenich Venturing 9 people	Maastricht	NL	Pre-Seed–Late Stage	$108K – $5.4M	+ Add to CRM
EDB Investments 11 people	—	SG	Seed–Series B	—	+ Add to CRM
HealthCap 11 people	Stockholm	SE	Seed–Series A	—	+ Add to CRM
TVM Capital 8 people	Munchen	DE	Seed–Late Stage	$1.1M – $16.2M	+ Add to CRM
Droia Ventures 7 people	Zaventem	BE	Seed–Series A	$540K	+ Add to CRM
PhotonVentures 7 people	Breukelen	NL	Seed–Series A	$1.1M – $2.7M	+ Add to CRM
Forbion 1 person	Amsterdam	NL	Pre-Seed–Late Stage	—	+ Add to CRM
Inkef 9 people	Amsterdam	NL	Seed–Series A	—	+ Add to CRM
Nina Capital 6 people	Barcelona	ES	Pre-Seed–Series A	$216K – $1.6M	+ Add to CRM
Clay Capital 5 people	—	SG	Seed–Late Stage	$3M – $8M	+ Add to CRM
Debiopharm Innovation Fund 5 people	Lausanne	CH	Series A–Late Stage	$3M – $5M	+ Add to CRM
HEARTFELT_ 8 people	Berlin	DE	Pre-Seed–Series A	—	+ Add to CRM
Pureos Bioventures 8 people	Pfäffikon	CH	Seed–Series A	—	+ Add to CRM
KIKK Capital 4 people	Roosendaal	NL	Seed–Series A	$540K – $1.6M	+ Add to CRM
Thuja Capital 7 people	Utrecht	NL	Seed–Series B	—	+ Add to CRM